Alnylam Pharmaceuticals
ALNY
#650
Rank
NZ$53.81 B
Marketcap
$417.23
Share price
0.28%
Change (1 day)
35.19%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company